FDA order keeps radiology AI under 510(k) premarket review

Sep 17, 2026 · Issue 7 · 5 sources, 6 articles

According to two trade sources, an FDA order keeps radiology AI under 510(k) review (17–18 September 2026). A separate analysis says the regulatory risks are already present.

Who is affected and how

medtech company

Revenue for radiology AI remains tied to premarket clearance, so the 510(k) plan and documentation need to be maintained.

doctor

Check the authorization status of radiology AI tools before adopting them.

Sources

• FDA Order Keeps 510(k) Review for Radiology AI… | Health Sensehealthsensemag.com · Sep 17, 2026
• FDA keeps radiology AI under 510(k) review; telehealth coalition seeks federal licensure path; UW Health sorts 100 new AI features by risk; Angle Health raises $600 million | Physician in the Loopphysicianintheloop.org · Sep 19, 2026
• FDA Keeps Radiology AI Revenue Tied to Premarket Clearancepymnts.com · Sep 17, 2026
• Radiology AI: the Regulatory Risks are Already Herereed smith llp · Sep 18, 2026
• Radiology AI: the Regulatory Risks are Already Here | ReedSmithreedsmith.com · Sep 18, 2026

Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.